Prof Anthony Gordon

image of Anthony Gordon

Bio

Professor Anthony Gordon is the Chair in Anaesthesia and Critical Care at Imperial College and is a Consultant in Intensive Care Medicine based at St Mary's Hospital. His research interests are focused on translational studies in sepsis. He leads a number of multi-centre clinical trials and his multi-discipliary team are developing "Personalised Medicine for Sepsis" using multiple -omic techniques, as well as the use of AI. His research is focused on clinical trials and translational studies in sepsis.

Professor Gordon is the UK Chief Investigator for the international REMAP-CAP platform trial evaluating treatments for COVID-19. This has demonstrated in severe COVID-19, that the IL-6 receptor antagonists, tocilizumab and sarilumab, saves lives and speed up recovery, as do corticosteroids. REMAP-CAP is now the UK national platform trial evaluating treatments for patients hospitalised due to influenza.